Pharmacodynamic analysis of ceftriaxone, gatifloxacin,and levofloxacin against Streptococcus pneumoniae with the use of Monte Carlo simulation.

Abstract:

STUDY OBJECTIVE:To evaluate the pharmacodynamics of four intravenous antimicrobial regimens-ceftriaxone 1 g, gatifloxacin 400 mg, levofloxacin 500 mg, and levofloxacin 750 mg, each every 24 hours-against recent Streptococcus pneumoniae isolates. DESIGN:Pharmacodynamic analysis using Monte Carlo simulation. DATA SOURCE:The Surveillance Network (TSN) 2002 database. MEASUREMENTS AND MAIN RESULTS:Streptococcus pneumoniae isolates (7866 isolates) were stratified according to penicillin susceptibilities as follows: susceptible (4593), intermediate (1986), and resistant (1287). Risk analysis software was used to simulate 10,000 patients by integrating published pharmacokinetic parameters, their variability, and minimum inhibitory concentration (MIC) distributions from the TSN database. Probability of target attainment was determined for percentage of time above the MIC (%T > MIC) from 0-100% for ceftriaxone and area under the concentration-time curve (AUC):MIC ratio from 0-150 for the fluoroquinolones. For ceftriaxone, probability of target attainment remained 90% or greater against the three isolate groups until a %T > MIC of 70% or greater, and it remained 90% or greater against susceptible and intermediate isolates over the entire interval (%T > MIC 0-100%). For levofloxacin 500 mg, probability of target attainment was 90% at an AUC:MIC < or = 30, but the curve declined sharply with further increases in pharmacodynamic target. Levofloxacin 750 mg achieved a probability of target attainment of 99% at an AUC:MIC ratio < or = 30; the probability remained approximately 90% until a target of 70 or greater, when it declined steeply. Gatifloxacin demonstrated a high probability (99%) of target attainment at an AUC:MIC ratio < or = 30, and it remained above 90% until a target of 70. CONCLUSION:Ceftriaxone maintained high probability of target attainment over a broad range of pharmacodynamic targets regardless of penicillin susceptibility (%T > MIC 0-60%). Levofloxacin 500 mg maintained high probability of target attainment for AUC:MIC ratios 0-30; whereas, levofloxacin 750 mg and gatifloxacin maintained high probability of target attainment for AUC:MIC ratios 0-60. Rate of decline in the pharmacodynamic curve was most pronounced for the two levofloxacin regimens and more gradual for gatifloxacin and ceftriaxone.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Frei CR,Burgess DS

doi

10.1592/phco.2005.25.9.1161

subject

Has Abstract

pub_date

2005-09-01 00:00:00

pages

1161-7

issue

9

eissn

0277-0008

issn

1875-9114

journal_volume

25

pub_type

杂志文章
  • Bar code documentation of pharmacotherapy services in intensive care units.

    abstract::Bar code technology has been used for 5 years to improve the efficiency of identifying and documenting clinical pharmacy services at our institution. Data for an entire year (1993) were analyzed to quantify the nature and magnitude of pharmacy services provided for critically ill patients in intensive care units (ICU)...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Zarowitz BJ,Petitta A,Rudis MI,Horst HM,Hyzy R

    更新日期:1996-03-01 00:00:00

  • Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.

    abstract:STUDY OBJECTIVE:To determine clinical and microbiologic success in patients receiving adjunctive aerosolized antibiotics for the treatment of ventilator-associated pneumonia (VAP). DESIGN:Retrospective medical record review. SETTING:Level I trauma intensive care unit of a large academic medical center. PATIENTS:Fort...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.29.9.1054

    authors: Czosnowski QA,Wood GC,Magnotti LJ,Croce MA,Swanson JM,Boucher BA,Fabian TC

    更新日期:2009-09-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of fluoroquinolones.

    abstract::The pharmacokinetic characteristics of levofloxacin, moxifloxacin, and gatifloxacin include excellent oral bioavailability (90-99%), extensive penetration into tissues and body fluids, and an elimination half-life (6-12 hrs) that allows for once-daily dosing in patients with normal renal function. Levofloxacin and gat...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.16.233s.33992

    authors: Rodvold KA,Neuhauser M

    更新日期:2001-10-01 00:00:00

  • Falsely low hemoglobin A1c levels in a patient receiving ribavirin and peginterferon alfa-2b for hepatitis C.

    abstract::The effect of treatment for hepatitis C viral infection on hemoglobin A(1c) (A1C) levels is not well described in the literature. We describe a 59-year-old man with type 2 diabetes mellitus whose A1C level became falsely low when ribavirin and peginterferon alfa-2b therapy were started for treatment of hepatitis C. Af...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.29.1.121

    authors: Gross BN,Cross LB,Foard JC,Wood YA

    更新日期:2009-01-01 00:00:00

  • Mechanisms of action of hormonal emergency contraceptives.

    abstract::Hormonal emergency contraceptives have been used to prevent unwanted pregnancy for more than 3 decades. The mechanisms of action of the regimen containing a combination of estrogen and progestin, known as the Yuzpe regimen, and those of the levonorgestrel regimen continue to be controversial, especially over the possi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.30.2.158

    authors: Leung VW,Levine M,Soon JA

    更新日期:2010-02-01 00:00:00

  • Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia.

    abstract::Pneumocystis carinii pneumonia (PCP) is the most common illness associated with the acquired immunodeficiency syndrome (AIDS) in the United States and also occurs in immunocompromised persons not infected with the human immunodeficiency virus.. Several advances have taken place in the treatment and prophylaxis of PCP,...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Warren E,George S,You J,Kazanjian P

    更新日期:1997-09-01 00:00:00

  • Acetaminophen-related acute renal failure without fulminant liver failure.

    abstract:BACKGROUND:Our patient experienced acute renal failure but not fulminant hepatic failure from acetaminophen toxicity. OBJECTIVE:To review the clinical and laboratory characteristics of similar cases of acetaminophen nephrotoxicity. METHODS:A MEDLINE search and medical record search at two large teaching hospitals. R...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Eguia L,Materson BJ

    更新日期:1997-03-01 00:00:00

  • A case report of warfarin resistance due to azathioprine and review of the literature.

    abstract::A 32-year-old woman with a history of deep vein thrombosis (DVT), steroid-dependent ulcerative colitis, and osteoporosis was prescribed azathioprine for a steroid-sparing effect. Stable, therapeutic international normalized ratios (INRs) were obtained with warfarin 35 mg/week during a 6-week postpartum course to treat...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.3.355.34208

    authors: Havrda DE,Rathbun S,Scheid D

    更新日期:2001-03-01 00:00:00

  • Ceftolozane/Tazobactam Pharmacokinetics in a Critically Ill Adult Receiving Continuous Renal Replacement Therapy.

    abstract::Limited data are available on ceftolozane/tazobactam dosing in patients receiving continuous renal replacement therapy (CRRT). Thus we performed a pharmacokinetic analysis of intravenous ceftolozane/tazobactam in a critically ill patient receiving CRRT at our medical center. A 47-year-old critically ill man with multi...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.1744

    authors: Bremmer DN,Nicolau DP,Burcham P,Chunduri A,Shidham G,Bauer KA

    更新日期:2016-05-01 00:00:00

  • The place of selective serotonin reuptake inhibitors in the treatment of panic disorder.

    abstract::Panic disorder is a frequently chronic condition with extensive patterns of psychiatric comorbidity. Optimum pharmacotherapy with traditional agents is limited by side effects, long-term tolerability, and other problems. Recent research findings support the characterization of panic disorder as an illness involving de...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: DeVane CL

    更新日期:1997-03-01 00:00:00

  • Determination of fluoxetine and norfluoxetine concentrations in cadaveric allograft skin.

    abstract::Fluoxetine hydrochloride is the sixth most prescribed drug in the United States and is administered to treat major depression. A cadaveric skin donation was obtained from a 46-year-old woman who died as a result of a fluoxetine overdose. Due to the potential penetration of the drug and its major metabolite, norfluoxet...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Neudeck BL,Taddonio TE,Garner WL,Welage LS

    更新日期:1998-07-01 00:00:00

  • Options for the management of mucosal candidiasis in patients with AIDS and HIV infection.

    abstract::Oropharyngeal candidiasis may be the first manifestation of human immunodeficiency viral (HIV) infection, and more than 90% of patients with the acquired immunodeficiency syndrome (AIDS) develop the disease. Although numerous antifungal agents are available, azoles, both topical (clotrimazole) and systemic (fluconazol...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.1.76.30509

    authors: Vazquez JA

    更新日期:1999-01-01 00:00:00

  • Tacrolimus toxicity associated with concomitant metoclopramide therapy.

    abstract::Subtherapeutic tacrolimus trough concentrations were noted in a 52-year-old woman who had undergone liver transplantation. Her tacrolimus dosage was increased from 7 to 28 mg twice/day, and ketoconazole therapy was added; however, her tacrolimus concentration remained undetectable. Metoclopramide 10 mg 4 times/day was...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.5.532.33357

    authors: Prescott WA Jr,Callahan BL,Park JM

    更新日期:2004-04-01 00:00:00

  • Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome.

    abstract:STUDY OBJECTIVES:To evaluate the efficacy of a single, low-dose injection of botulinum toxin type A in relieving pain in Korean patients with piriformis syndrome resistant to conventional therapy, and to assess the drug's influence on these patients' quality of life. DESIGN:Prospective, single-site, open-label trial. ...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.27.5.657

    authors: Yoon SJ,Ho J,Kang HY,Lee SH,Kim KI,Shin WG,Oh JM

    更新日期:2007-05-01 00:00:00

  • Optimizing pediatric dosing: a developmental pharmacologic approach.

    abstract::Many physiologic differences between children and adults can result in age-related differences in pharmacokinetics. Understanding the effects of age on bioavailability, volume of distribution, protein binding, hepatic metabolic isoenzymes, and renal elimination can provide insight into optimizing doses for pediatric p...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.29.6.680

    authors: Anderson GD,Lynn AM

    更新日期:2009-06-01 00:00:00

  • Changing oral contraceptives from prescription to over-the-counter status: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.

    abstract::Addressing the issue of unintended pregnancy is a national priority. One proposed strategy to reduce unintended pregnancy is to improve access to oral contraceptives by changing them to over-the-counter (OTC) status. Existing data indicate that oral contraceptives meet safety criteria required of OTC products. Availab...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.31.4.424

    authors: McIntosh J,Rafie S,Wasik M,McBane S,Lodise NM,El-Ibiary SY,Forinash A,Kachlic MD,Rowe E,Besinque K

    更新日期:2011-04-01 00:00:00

  • Prolonged paralysis associated with long-term pancuronium use.

    abstract::We cared for a 4-year-old patient who had undergone orthotopic liver transplantation and was placed on a ventilator for respiratory distress associated with Pneumocystis carinii pneumonia. The neuromuscular blocking agent pancuronium bromide 1.0-1.2 mg every hour as needed was used to facilitate artificial ventilation...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/j.1875-9114.1989.tb04121.x

    authors: Haas JL,Shaefer MS,Miwa LJ,Wood RP,Shaw BW Jr

    更新日期:1989-01-01 00:00:00

  • Active transport of nitrofurantoin into human milk.

    abstract:STUDY OBJECTIVE:To determine the extent to which nitrofurantoin is transferred into human milk. DESIGN:Prospective, single-dose pharmacokinetic study. SETTING:University-affiliated clinical research center. PATIENTS:Four healthy lactating women 8-26 weeks postpartum. INTERVENTION:All subjects received a single, ora...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.21.7.669.34574

    authors: Gerk PM,Kuhn RJ,Desai NS,McNamara PJ

    更新日期:2001-06-01 00:00:00

  • Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.

    abstract:STUDY OBJECTIVE:To determine whether early administration of adjuvant β-lactam in combination with vancomycin (COMBO) affects clinical outcomes compared to standard vancomycin therapy alone (STAN) among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection. DESIGN:Retrospective, multic...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1002/phar.2034

    authors: Casapao AM,Jacobs DM,Bowers DR,Beyda ND,Dilworth TJ,REACH-ID Study Group.

    更新日期:2017-11-01 00:00:00

  • Peak antifactor xa activity produced by dalteparin treatment in patients with renal impairment compared with controls.

    abstract:STUDY OBJECTIVE:To evaluate the relationship between impaired renal function and antifactor Xa activity in patients receiving dalteparin. DESIGN:Open-label prospective study. SETTING:Inpatient and outpatient units of a large teaching hospital. SUBJECTS:Eleven patients with renal impairment and 11 control subjects wi...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.2005.25.6.817

    authors: Shprecher AR,Cheng-Lai A,Madsen EM,Cohen HW,Sinnett MJ,Wong ST,Billett HH

    更新日期:2005-06-01 00:00:00

  • Verapamil hydrochloride: pharmacological properties and role in cardiovascular therapeutics.

    abstract::Verapamil hydrochloride, a prototype calcium antagonist, is now marketed in the United States for the acute treatment of supraventricular tachyarrhythmias and for chronic management of vasospastic and chronic stable angina. It inhibits the slow inward channel in in the heart and blocks calcium influx in smooth muscle....

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1982.tb03210.x

    authors: Baky SH,Singh BN

    更新日期:1982-11-01 00:00:00

  • Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review.

    abstract::Pulmonary hypertension (PH) is often caused by left heart disease (LHD) such as heart failure (HF) or valvular heart disease. Historically, few randomized controlled trials have evaluated the off-label use of medications for treating pulmonary arterial hypertension (PAH) in patients with PH-LHD. However, multiple rand...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2314

    authors: Kido K,Coons JC

    更新日期:2019-09-01 00:00:00

  • Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics.

    abstract::Anticoagulation clinics emerged as a means to optimize warfarin effectiveness and minimize bleeding risks. Anticoagulation clinics have traditionally been warfarin-based models due to the need for frequent blood-level monitoring, drug interactions, dietary considerations, and periprocedural management with warfarin. T...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1991

    authors: Mohammad I,Korkis B,Garwood CL

    更新日期:2017-10-01 00:00:00

  • Pharmaceutical properties of paclitaxel and their effects on preparation and administration.

    abstract::Paclitaxel is a mainstay in the treatment of ovarian and breast cancers, and its use in other malignancies is being explored. Although it has great clinical utility, the drug and its formulation components pose a number of challenges to pharmacists and nurses. Paclitaxel is insoluble in water and is formulated in an e...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Trissel LA

    更新日期:1997-09-01 00:00:00

  • Recommendations for generating, evaluating, and implementing drug-drug interaction evidence.

    abstract::In October 2009, a 2-day, multistakeholder, national conference was held in Rockville, Maryland, to discuss and propose methods to improve the drug-drug interaction (DDI) evidence base and its evaluation and integration into clinical decision support (CDS) systems. The conference featured participants representing con...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/j.1875-9114.2012.01024.x

    authors: Hines LE,Malone DC,Murphy JE

    更新日期:2012-04-01 00:00:00

  • Clinical pharmacology of rapacuronium bromide, a new short-acting neuromuscular blocking agent.

    abstract::Rapacuronium is a new steroidal, nondepolarizing, neuromuscular blocking agent. It appears to be the least potent of all available nondepolarizing muscle relaxants. Its onset of action resembles that of succinylcholine, and its recovery times are shorter than those of other nondepolarizing agents. The clinical duratio...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.15.1118.30572

    authors: Larijani GE,Zafeiridis A,Goldberg ME

    更新日期:1999-10-01 00:00:00

  • Changes in pharmacy practice faculty 1995-2001: implications for junior faculty development.

    abstract:OBJECTIVE:To compare changes in United States pharmacy practice faculty demographics from 1995-2001 and to discuss the implications for junior faculty development. METHODS:Demographic data were extracted from the American Association of Colleges of Pharmacy institutional research system for academic years 1995-1996 an...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.22.7.445.33678

    authors: Raehl CL

    更新日期:2002-04-01 00:00:00

  • Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials.

    abstract::Clinical outcomes that measure how patients feel, function, or survive are the most important and relevant outcomes of therapy in clinical trials and in clinical practice. Surrogate end points, which do not directly measure clinical benefit to the patient, may function as substitutes for clinical end points in clinica...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.2005.25.12part2.109S

    authors: Powers JH

    更新日期:2005-12-01 00:00:00

  • Methods to assess the economic outcomes of clinical pharmacy services.

    abstract::Studies that demonstrate the clinical and economic burden of drug misadventures have been published. The economic burden of drug misadventures likely exceeds $100 billion annually in the United States alone. Clinical pharmacy services (CPS) have been shown to reduce negative clinical outcomes and costs of drug therapy...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.16.243s.35018

    authors: Schumock GT

    更新日期:2000-10-01 00:00:00

  • Strategies to reduce toxicities and improve outcomes in renal transplant recipients.

    abstract::Ongoing improvements in immunosuppression and posttransplantation care have dramatically improved patient and graft outcomes after transplantation. The frequency of graft loss due to acute rejection has declined considerably as a result of the availability of a variety of more potent immunosuppressive agents and proba...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.5.316.33198

    authors: Lo A,Alloway RR

    更新日期:2002-03-01 00:00:00